[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Tue, May 5th, 2026

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Tue, May 5th, 2026

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

OxyContin maker Purdue Pharma's settlement, by the numbers

OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids is taking effect Friday and the company is being replaced by a new entity

Biotech, Banks, and Bonds: Trading the Fed’s April Meeting

Late April Fed meeting may reset rate expectations. Biotech, financials, and long-duration Treasury ETF ideas for traders positioning both sides of Powell.

OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence

OxyContin maker Purdue Pharma has been ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller

Judge postpones OxyContin-maker Purdue Pharma's sentencing to let opioid victims attend in person

A judge has rescheduled a hearing in which she is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the U.S. government

The Next Big AI Winner Might Not Be a Tech Company

Lilly’s AI push shows how non-tech firms can dominate the next wave.

NVDA : 198.92 (+0.22%)
$SPX : 7,253.76 (+0.74%)
CNTA : 39.68 (-0.05%)
LLY : 978.19 (+1.06%)
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here?

Cyclerion stock soared on a merger agreement with privately held Korsana Biosciences. But there are ample reasons for disciplined investors to avoid chasing the rally in CYCN shares.

CYCN : 3.22 (-1.23%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.